Since we're waiting on some news flow, would like to run some scenario analysis past the crew.
I used forward PE multiples to determine the expected earnings and than gross this back up assuming a 30% margin. I then divided this by $10 x 12 months to find the number of patients required to justify the current market cap. The conversion % required is based solely on dementia app for the AU and then EU + AU markets.
IMO, current market cap is extremely undervalued. I guess all that is left is proof of uptake which all signs are signalling significant uptake due to:
1. Clinical utility.
2. Cost effectiveness.
3. Funding documentation - if you read the ACFI, it is actually very cumbersome.
Please feel free to shoot holes through and any recommendations to adjust parameters.
BPB
Since we're waiting on some news flow, would like to run some...
-
- There are more pages in this discussion • 19,901 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $65.43M | |||
| Open | High | Low | Value | Volume |
| 4.0¢ | 4.0¢ | 3.8¢ | $78.18K | 1.972M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1006631 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 385241 | 3 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| PCK (ASX) Chart |